Denied permission for hijab, woman drops plan to join teaching course

Bengaluru, June 23: A head constable from Karnataka State Reserve Police (KSRP) committed suicide on board a bus after testing positive for COVID-19 in the city.

As per sources, the 50-year-old head constable had tested positive for coronavirus last evening and today he was being taken to a hospital in KSRP bus.

It is learned that he hanged himself to death inside the bus as there was no one else.

Mangaluru, Apr 26: City Police Commissioner P S Harsha on Sunday said that the news about the implementation of seal down in some wards of Mangaluru city is fake and urged the public not to pay any heed to it.

Taking to twitter, Mr Harsha wrote, ''Some miscreants are floating some old speculative…TV news reports of seal down in some wards of Mangaluru city. It’s fake news.....Don’t Heed to fake news.''

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.